Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.22, Down -0.40

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

Vor Biopharma Inc (NASDAQ: VOR) closed the day trading at $0.22 down -0.40% from the previous closing price of $0.22. In other words, the price has decreased by -$0.40 from its previous closing price. On the day, 1.29 million shares were traded. VOR stock price reached its highest trading level at $0.23 during the session, while it also had its lowest trading level at $0.2109.

Ratios:

For a better understanding of VOR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.40.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on July 26, 2022, initiated with a Outperform rating and assigned the stock a target price of $18.

On April 27, 2022, Goldman started tracking the stock assigning a Neutral rating and target price of $6.

On December 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $26.H.C. Wainwright initiated its Buy rating on December 17, 2021, with a $26 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 13 ’25 when Attar Eyal C. sold 2,227 shares for $1.42 per share. The transaction valued at 3,162 led to the insider holds 126,625 shares of the business.

EYAL ATTAR bought 2,227 shares of VOR for $3,073 on Feb 13 ’25. On Feb 10 ’25, another insider, Attar Eyal C., who serves as the CHIEF MEDICAL OFFICER of the company, sold 2,554 shares for $1.37 each. As a result, the insider received 3,499 and left with 128,852 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 27965926 and an Enterprise Value of -1399523.

Stock Price History:

The Beta on a monthly basis for VOR is -0.51, which has changed by -0.8216 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, VOR has reached a high of $1.80, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -50.27%, while the 200-Day Moving Average is calculated to be -73.98%.

Shares Statistics:

Over the past 3-months, VOR traded about 1.97M shares per day on average, while over the past 10 days, VOR traded about 1672070 shares per day. A total of 124.85M shares are outstanding, with a floating share count of 76.86M. Insiders hold about 38.49% of the company’s shares, while institutions hold 42.26% stake in the company. Shares short for VOR as of 1747267200 were 2758424 with a Short Ratio of 1.40, compared to 1744675200 on 1313534. Therefore, it implies a Short% of Shares Outstanding of 2758424 and a Short% of Float of 6.0599998.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.